Filing Details
- Accession Number:
- 0001104659-18-048802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-01 17:12:19
- Reporting Period:
- 2018-07-30
- Accepted Time:
- 2018-08-01 17:12:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1330436 | Liquidia Technologies Inc | LQDA | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1419148 | Canaan Viii Lp | C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880 | No | No | Yes | No | |
1552200 | Canaan Partners Viii Llc | C/O Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT 06880 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-30 | 87,837 | $0.00 | 90,536 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-30 | 89,630 | $0.00 | 180,166 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-30 | 31,471 | $0.00 | 211,637 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-30 | 680,266 | $0.00 | 891,903 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-30 | 944,127 | $0.00 | 1,836,030 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-30 | 727,273 | $11.00 | 2,563,303 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2018-07-30 | 918,657 | $0.00 | 87,837 | $0.00 |
Common Stock | Series A-1 Preferred Stock | Disposition | 2018-07-30 | 650,427 | $0.00 | 89,630 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-07-30 | 222,529 | $0.00 | 31,471 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2018-07-30 | 5,254,658 | $0.00 | 680,266 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2018-07-30 | 15,887,155 | $0.00 | 944,127 | $0.00 |
Series D Preferred Stock | Warrant to purchase Series D Preferred Stock | Disposition | 2018-07-30 | 578,498 | $0.00 | 578,498 | $0.01 |
Common Stock | Warrant to purchase Common Stock | Acquisiton | 2018-07-30 | 34,378 | $0.00 | 34,378 | $0.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2017-01-09 | 2026-12-31 | No | 4 | J | Direct |
34,378 | 2017-01-09 | 2026-12-31 | No | 4 | J | Direct |
Footnotes
- The Series A preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0956-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- The Series A-1 preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1378-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- The Series B preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1414-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
- Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrant to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.
- Shares held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Canaan LP. Investment and voting decisions with respect to the shares held by Canaan LP are made by the managers of Canaan LLC, collectively. Canaan LLC disclaims Section 16 beneficial ownership of the shares held by Canaan LP, except to the extent, if any, of its pecuniary interest therein.